Effect of Dead Sea Climatotherapy on Psoriasis; A Prospective Cohort Study

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2020 Apr 8

PMID 32258044

Citations 10

Authors

Thomas Emmanuel

Dorte Lybaek

Claus Johansen

Lars Iversen

Affiliations

Soon will be listed here.

Abstract

Dead Sea climatotherapy (DSC) is a treatment option for psoriasis in Denmark. However, the response to DSC has not been particularly well studied. We sought to determine effectiveness and response duration of DSC on psoriasis-related outcome parameters. Eighteen patients participated in a 4-week treatment program in Ein Gedi in Israel. Treatment, consisting of sun exposure and bathing, was individualized. DSC was associated with a mean 13.0-point reduction (88%) in Psoriasis Area and Severity Index and a mean reduction of 2.3 (76.7%) on the 5-point Investigator's Global Assessment Scale. Furthermore, patients' quality of life improved measured by the Dermatology Quality of Life Index and EuroQol 5D index values. The mean time from treatment end to reappearance of visible skin symptoms was 93.8 days (SD: 62.5, range: 31-219 days). Our results confirm that DSC has an immediate effect on skin manifestations and improves quality of life, but long-term disease control is not observed.

Citing Articles

Psoriasis Treatments: Emerging Roles and Future Prospects of MicroRNAs.

Teo L, Juantuah-Kusi N, Subramanian G, Sampath P Noncoding RNA. 2025; 11(1).

PMID: 39997616 PMC: 11858470. DOI: 10.3390/ncrna11010016.

Psychosocial impact of climatotherapy in young patients with psoriasis: a 3-month cohort study.

Nordgren M, Duvetorp A Front Med (Lausanne). 2024; 11:1458394.

PMID: 39534221 PMC: 11554493. DOI: 10.3389/fmed.2024.1458394.

Psoriasis and Seasonality: Exploring the Genetic and Epigenetic Interactions.

Niedzwiedz M, Skibinska M, Ciazynska M, Noweta M, Czerwinska A, Krzyscin J Int J Mol Sci. 2024; 25(21).

PMID: 39519223 PMC: 11547062. DOI: 10.3390/ijms252111670.

Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory.

Emmanuel T, Ignatov B, Bertelsen T, Litman T, Nielsen M, Brent M Int J Mol Sci. 2024; 25(11).

PMID: 38892277 PMC: 11172747. DOI: 10.3390/ijms25116086.

Unveiling the Therapeutic Potential and Healthcare Applications of Marine Therapy: A Systematic Review with Meta-Analysis and Meta-Regression.

Shim S, Shin D, Kim S, Kim Y, Lee K Mar Drugs. 2023; 21(12).

PMID: 38132925 PMC: 10744920. DOI: 10.3390/md21120604.

References

David M, Tsukrov B, Adler B, Hershko K, Pavlotski F, Rozenman D . Actinic damage among patients with psoriasis treated by climatotherapy at the Dead Sea. J Am Acad Dermatol. 2005; 52(3 Pt 1):445-50. DOI: 10.1016/j.jaad.2004.11.019. View

Parisi R, Symmons D, Griffiths C, Ashcroft D . Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2012; 133(2):377-85. DOI: 10.1038/jid.2012.339. View

Kopel E, Levi A, Harari M, Ruzicka T, Ingber A . Effect of the Dead Sea climatotherapy for psoriasis on quality of life. Isr Med Assoc J. 2013; 15(2):99-102. View

Cattaneo A, Violetti S, Tavecchio S, Bruni E, Carrera C, Crosti C . Tomesa balneophototherapy in mild to severe psoriasis: a retrospective clinical trial in 174 patients. Photodermatol Photoimmunol Photomed. 2012; 28(3):169-71. DOI: 10.1111/j.1600-0781.2012.00659.x. View

Leibovici V, Sagi E, Siladji S, Greiter J, Greiter F, Holubar K . Seasonal variation of UV radiation at the Dead Sea. Dermatologica. 1987; 174(6):290-2. DOI: 10.1159/000249201. View

Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C . A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. Br J Dermatol. 2019; 182(6):1348-1358. PMC: 7317420. DOI: 10.1111/bjd.18851. View

Snellman E, Lauharanta J, Reunanen A, Jansen C, Kallio M, Luoma J . Effect of heliotherapy on skin and joint symptoms in psoriasis: a 6-month follow-up study. Br J Dermatol. 1993; 128(2):172-7. DOI: 10.1111/j.1365-2133.1993.tb15147.x. View

Schiener R, Brockow T, Franke A, Salzer B, Peter R, Resch K . Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial. Arch Dermatol. 2007; 143(5):586-96. DOI: 10.1001/archderm.143.5.586. View

Harari M, Czarnowicki T, Fluss R, Ruzicka T, Ingber A . Patients with early-onset psoriasis achieve better results following Dead Sea climatotherapy. J Eur Acad Dermatol Venereol. 2011; 26(5):554-9. DOI: 10.1111/j.1468-3083.2011.04099.x. View

10.

Egeberg A, Ottosen M, Gniadecki R, Broesby-Olsen S, Dam T, Bryld L . Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis. Br J Dermatol. 2017; 178(2):509-519. DOI: 10.1111/bjd.16102. View

11.

Shani J, Harari M, Hristakieva E, Seidl V . Dead-Sea climatotherapy versus other modalities of treatment for psoriasis: comparative cost-effectiveness. Int J Dermatol. 1999; 38(4):252-62. DOI: 10.1046/j.1365-4362.1999.00583.x. View

12.

Kim W, Jerome D, Yeung J . Diagnosis and management of psoriasis. Can Fam Physician. 2017; 63(4):278-285. PMC: 5389757. View

13.

Hodak E, Gottlieb A, Segal T, Politi Y, Maron L, Sulkes J . Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: combined effects on epidermal and immunologic activation. J Am Acad Dermatol. 2003; 49(3):451-7. DOI: 10.1067/s0190-9622(03)00916-2. View

14.

Tabolli S, Calza A, Di Pietro C, Sampogna F, Abeni D . Quality of life of psoriasis patients before and after balneo -- or balneophototherapy. Yonsei Med J. 2009; 50(2):215-21. PMC: 2678696. DOI: 10.3349/ymj.2009.50.2.215. View

15.

Harari M, Novack L, Barth J, David M, Friger M, Moses S . The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea. Int J Dermatol. 2007; 46(10):1087-91. DOI: 10.1111/j.1365-4632.2007.03278.x. View

16.

Dawe R, Yule S, Cameron H, Moseley H, Ibbotson S, Ferguson J . A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br J Dermatol. 2005; 153(3):613-9. DOI: 10.1111/j.1365-2133.2005.06663.x. View

17.

Brockow T, Schiener R, Franke A, Resch K, Peter R . A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2007; 21(8):1027-37. DOI: 10.1111/j.1468-3083.2007.02152.x. View

18.

Grzybowski A, Pietrzak K . From patient to discoverer--Niels Ryberg Finsen (1860–1904) --the founder of phototherapy in dermatology. Clin Dermatol. 2012; 30(4):451-5. DOI: 10.1016/j.clindermatol.2011.11.019. View

19.

Frentz G, Olsen J, Avrach W . Malignant tumours and psoriasis: climatotherapy at the Dead Sea. Br J Dermatol. 1999; 141(6):1088-91. DOI: 10.1046/j.1365-2133.1999.03161.x. View

20.

Norris D, Photiou L, Tacey M, Dolianitis C, Varigos G, Foley P . Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population. J Dermatolog Treat. 2017; 28(8):731-736. DOI: 10.1080/09546634.2017.1329501. View